January 20th, 2021

We are pleased to announce that Montagu Equity Partners (“Montagu”), an independent European investment fund, has entered into exclusive negotiations with Qualium Investissement (“Qualium”) to acquire IMV Technologies (the “Company”).

Founded in 1963 and based in Normandy, IMV Technologies is the world leader in the design, manufacture, distribution and service of equipment and supplies used in animal reproduction and animal reproductive and clinical imaging. Its Life Sciences division features products used in human medical research and assisted reproduction. With operations in France, Brazil, China, India, the Netherlands, Russia, South Africa, the United Kingdom and the United States, and a vast network of distributors across more than 120 countries, IMV Technologies generates more than 85% of its revenue internationally.

Alain de Lambilly, CEO of IMV Technologies, declared: “We are delighted to be partnering with Montagu and see considerable opportunity ahead. The firm’s deep expertise in the healthcare and technology sectors will be a major asset for our Company. Montagu’s partnership will enable us to further develop the Company through significant investments in research and innovation. IMV Technologies thanks Qualium Investissement for bringing us to this place in our journey.”

The Transaction is subject to the final and definitive agreement between the parties and customary conditions and provisions.

In the context of the Transaction, Sycomore Corporate Finance acted as exclusive financial advisor to IMV Technologies and its management. The Transaction team comprised Pierre-Arnaud de Lacharrière, Jihane Kabouya, Marion Camboulive and Maxime Bompard.